Patents by Inventor Thomas Slezak

Thomas Slezak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130267429
    Abstract: Biological sample target classification, detection and selection methods are described, together with related arrays and oligonucleotide probes.
    Type: Application
    Filed: May 2, 2013
    Publication date: October 10, 2013
    Inventors: Shea GARDNER, Crystal J. JAING, Kevin MCLOUGHLIN, Thomas SLEZAK, James B. THISSEN, Marisa Wailam TORRES
  • Patent number: 8232058
    Abstract: Described are kits and methods useful for detection of respiratory pathogens (influenza A (including subtyping capability for H1, H3, H5 and H7 subtypes) influenza B, parainfluenza (type 2), respiratory syncytial virus, and adenovirus) in a sample. Genomic sequence information from the respiratory pathogens was analyzed to identify signature sequences, e.g., polynucleotide sequences useful for confirming the presence or absence of a pathogen in a sample. Primer and probe sets were designed and optimized for use in a PCR based, multiplexed Luminex assay to successfully identify the presence or absence of pathogens in a sample.
    Type: Grant
    Filed: January 22, 2007
    Date of Patent: July 31, 2012
    Assignee: Lawrence Livermore National Security, LLC
    Inventors: Mary McBride, Thomas Slezak, James M. Birch
  • Publication number: 20090305229
    Abstract: Described are kits and methods useful for detection of respiratory pathogens (influenza A (including subtyping capability for H1, H3, H5 and H7 subtypes) influenza B, parainfluenza (type 2), respiratory syncytial virus, and adenovirus) in a sample. Genomic sequence information from the respiratory pathogens was analyzed to identify signature sequences, e.g., polynucleotide sequences useful for confirming the presence or absence of a pathogen in a sample. Primer and probe sets were designed and optimized for use in a PCR based, multiplexed Luminex assay to successfully identify the presence or absence of pathogens in a sample.
    Type: Application
    Filed: January 22, 2007
    Publication date: December 10, 2009
    Applicant: LAWRENCE LIVERMORE NATIONAL SECURITY, LLC.
    Inventors: Mary McBride, Thomas Slezak, James M. Birch
  • Publication number: 20070172835
    Abstract: The present invention is directed to methods, compositions and kits for multiplex detection of pathogens, such as respiratory pathogens.
    Type: Application
    Filed: January 20, 2006
    Publication date: July 26, 2007
    Inventors: Mary McBride, Thomas Slezak, James Birch
  • Publication number: 20070111248
    Abstract: Described herein is the identification of nucleotide sequences specific to Francisella tularensis that serves as a marker or signature for identification of this bacterium. In addition, forward and reverse primers and hybridization probes derived from these nucleotide sequences that are used in nucleotide detection methods to detect the presence of the bacterium are disclosed.
    Type: Application
    Filed: December 21, 2006
    Publication date: May 17, 2007
    Inventors: Paula McCready, Lyndsay Radnedge, Gary Andersen, Linda Ott, Thomas Slezak, Thomas Kuczmarski, Elizabeth Vitalis
  • Publication number: 20060040268
    Abstract: Described herein is the identification of nucleotide sequences specific to Francisella tularensis that serves as a marker or signature for identification of this bacterium. In addition, forward and reverse primers and hybridization probes derived from these nucleotide sequences that are used in nucleotide detection methods to detect the presence of the bacterium are disclosed.
    Type: Application
    Filed: July 29, 2003
    Publication date: February 23, 2006
    Inventors: Paula McCready, Lyndsay Radnedge, Gary Andersen, Linda Ott, Thomas Slezak, Thomas Kuczmarski, Elizabeth Vitalis
  • Publication number: 20060019255
    Abstract: Described herein are the identification of nucleotide sequences specific to Brucella that serves as a marker or signature for identification of this bacterium. In addition, forward and reverse primers and hybridization probes derived from these nucleotide sequences that are used in nucleotide detection methods to detect the presence of the bacterium are disclosed.
    Type: Application
    Filed: July 29, 2003
    Publication date: January 26, 2006
    Inventors: Paula McCready, Lyndsay Radnedge, Gary Andersen, Linda Ott, Thomas Slezak, Thomas Kuczmarski
  • Publication number: 20060019254
    Abstract: Described herein are the identification of nucleotide sequences specific to Yersinia pestis that serves as a marker or signature for identification of this bacterium. In addition, forward and reverse primers and hybridization probes derived from these nucleotide sequences that are used in nucleotide detection methods to detect the presence of the bacterium are disclosed.
    Type: Application
    Filed: July 29, 2003
    Publication date: January 26, 2006
    Inventors: Paula McCready, Lyndsay Radnedge, Gary Andersen, Linda Ott, Thomas Slezak, Thomas Kuczmarski, Vladimir Motin